 BRYAN, Texas, June 09, 2021 GLOBE NEWSWIRE -- iBio, Inc. NYSEA:IBIO iBio or the Company, a biotech innovator and biologics contract manufacturing organization, announced today the appointment of Evert Eef Schimmelpennink to its Board of Directors, effective immediately. 